Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies.
The Journal of asthma : official journal of the Association for the Care of Asthma（2023）
摘要
The use of biologic therapies in moderate to severe asthma is not cost-effective compared to standard treatment alone.
更多查看译文
关键词
Biologicals,asthma,cost-effectiveness,incremental net benefit,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要